A Population-Based Nested Case-Control Study in Taiwan: Use of 5 -Reductase Inhibitors Did Not Decrease Prostate Cancer Risk in Patients With Benign Prostate Hyperplasia

Oncologist - United States
doi 10.1634/theoncologist.2011-0464